LMMY
Exousia Bio, Inc.
$0.44
+0.00 (+0.00%)
At close · Jul 7
Going-concern doubt
— flagged Jun 16, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has not yet established an ongoing source of revenue sufficient to cover its operating costs and allow it to continue as a going concern. The Company has accumulated deficit from inception (January 31, 2022) to February 28, 2026, of $288,623. These factors among others raise substantial doubt about the ability of the company to continue as a going concern for a reasonable period of time.”View the 10-Q filed Jun 16, 2026
Market Cap
$23.00M
Shares
52,500,000
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.44
Open$0.44
Day$0.44–0.44
52W$0.17–0.94
Avg vol 30d398
Short int10 · 0.0% float · 1.0d
Short vol72%
DataOct 2024–Jul 2026
Filing10-Q · Jun 16
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+20%
above
Price vs 50-day avg
+5%
above
RSI (14)
68
neutral
MACD trend
Positive
52-week position
35%
mid-range
Momentum
relative strength
1-month return
+22%
trailing
6-month return
+31%
trailing
YTD return
+40%
this year
Relative strength
+23%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Revenue growth
−67%
Y/Y
Gross margin
-93%
contracting
Balance sheet
$7.9K
net cash
Quant / Vol
risk profile
Volatility
278%
annualized · 1-yr
Max drawdown
−67%
past year
ATR
2.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ1-27 quarter ends
~Aug 31, 2026
Est
filed Jun 16, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+20%
Bullish
Price vs 50-day avg
+5%
Bullish
RSI (14)
68
Neutral
MACD trend
Positive
Bullish
52-week position
35%
Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $0
Now $0 · 35%
52-wk high $1
vs 200-day avg +20%
vs 50-day avg +5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Education & Training Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LMMY
this stock
Exousia Bio, Inc.
|
$23.00M | +40.0% | -67.4% | — | 0.0% |
|
EDU
New Oriental Education & Technology Group Inc.
|
$7.97B | -12.1% | +13.6% | — | 1.6% |
|
TAL
TAL Education Group
|
$5.63B | -7.0% | +33.7% | — | 5.2% |
|
LAUR
Laureate Education, Inc.
|
$5.58B | +18.4% | +19.5% | 21.3 | 3.7% |
|
CVSA
Covista Inc.
|
$4.57B | +31.0% | +12.9% | 21.0 | 4.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LMMY | +0.0% | +21.7% | +30.9% | +0.0% | +40.0% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | -0.9% | +20.3% | +23.3% | -0.1% | +30.3% |